Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in adults and children worldwide. NAFLD has become a severe health issue and it can progress towards a more severe form of the disease, the non-alcoholic steatohepatitis (NASH). A combination of environmental factors, host genetics, and gut microbiota leads to excessive accumulation of lipids in the liver (steatosis), which may result in lipotoxicity and trigger hepatocyte cell death, liver inflammation, fibrosis, and pathological angiogenesis. NASH can further progress towards liver cirrhosis and cancer. Over the last few years, cell-derived extracellular vesicles (EVs) have been identified as effective cell-to-cell messengers that transfer several bioactive molecules in target cells, modulating the pathogenesis and progression of NASH. In this review, we focused on recently highlighted aspects of molecular pathogenesis of NASH, mediated by EVs via their bioactive components. The studies included in this review summarize the state of art regarding the role of EVs during the progression of NASH and bring novel insight about the potential use of EVs for diagnosis and therapeutic strategies for patients with this disease.

Citations

Citations to this article as recorded by  

• Walnut fruit diaphragm ethanol extract ameliorates damage due to Triton WR‐1339‐induced hyperlipidemia in rats
  Esra Palabiyik, Ayse Nurseli Sulumer, Handan Uguz, Bahri Avci, Seda Askin, Hakan Askin
  European Journal of Lipid Science and Technology.2024;[Epub]     CrossRef
• Extracellular Vesicles and Their Correlation with Inflammatory Factors in an Experimental Model of Steatotic Liver Disease Associated with Metabolic Dysfunction
  Melina Belén Keingeski, Larisse Longo, Vitória Brum da Silva Nunes, Fabrício Figueiró, Danieli Rosane Dallemole, Adriana Raffin Pohlmann, Thalia Michele Vier Schmitz, Patrícia Luciana da Costa Lopez, Mário Reis Álvares-da-Silva, Carolina Uribe-Cruz
  Metabolic Syndrome and Related Disorders.2024; 22(5): 394.     CrossRef
• Natural linoleic acid from marine fungus Eutypella sp. F0219 blocks KEAP1/NRF2 interaction and ameliorates MASLD by targeting FABP4
  Chen-yan Wu, Yue Chen, Meng-ting Chen, Ting-ting Fu, Jin Liu, Fei-fei Liu, Cong-jun Xu, Wan-shan Li, Bao-li Li, Zhong-ping Jiang, Yong Rao, Ling Huang
  Free Radical Biology and Medicine.2024; 224: 630.     CrossRef
• Chrysin attenuates diabetic sarcopenia by regulating myogenic transcription factors and reducing muscle degradation in high glucose-exposed C2C12 cells and a type 2 diabetes animal model
  Dong Yeon Kim, Min-Kyung Kang
  Journal of Nutrition and Health.2024; 57(5): 469.     CrossRef
• Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism
  Marziyeh Anari, Hamzeh Karimkhanloo, Shuai Nie, Li Dong, Gio Fidelito, Jacqueline Bayliss, Stacey N. Keenan, John Slavin, Sihan Lin, Zhili Cheng, Jie Lu, Paula M. Miotto, William De Nardo, Camille J. Devereux, Nicholas A. Williamson, Matthew J. Watt, Magd
  Cell Reports.2024; 43(12): 115007.     CrossRef
• β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway
  Omayma AR Abo-Zaid, Fatma SM Moawed, Effet Soliman Ismail, Mostafa A. Farrag
  BMC Pharmacology and Toxicology.2023;[Epub]     CrossRef
• Phospholipid metabolism in the liver – Implications for phosphatidylserine in non-alcoholic fatty liver disease
  Marziyeh Anari, Magdalene K. Montgomery
  Biochemical Pharmacology.2023; 213: 115621.     CrossRef
• Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis
  Wenyan Zhang, Jing Zhang, Honglin Shi, Fang Liu, Haibin Yu, Hongbo Shi
  Hepatology International.2023; 17(5): 1170.     CrossRef
• Role of extracellular vesicles in nonalcoholic fatty liver disease
  Wei Jiang, Youhui Xu, Jou-Chen Chen, Yi-Hung Lee, Yushin Hu, Chang-Hai Liu, Enqiang Chen, Hong Tang, Hua Zhang, Dongbo Wu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease
  Melania Manco, Nadia Panera, Annalisa Crudele, Maria Rita Braghini, Marzia Bianchi, Donatella Comparcola, Rita De Vito, Giuseppe Maggiore, Anna Alisi
  Pediatric Research.2022; 91(7): 1781.     CrossRef
• The Neglected Role of Bile Duct Epithelial Cells in NASH
  Massimiliano Cadamuro, Alberto Lasagni, Samantha Sarcognato, Maria Guido, Roberto Fabris, Mario Strazzabosco, Alastair J. Strain, Paolo Simioni, Erica Villa, Luca Fabris
  Seminars in Liver Disease.2022; 42(01): 034.     CrossRef
• Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis
  Binjing Pan, Jing Cai, Pingping Zhao, Jingfang Liu, Songbo Fu, Gaojing Jing, Qianglong Niu, Qiong Li
  Osteoporosis International.2022; 33(11): 2275.     CrossRef
• Ethanol Extract of Pinus koraiensis Leaves Mitigates High Fructose-Induced Hepatic Triglyceride Accumulation and Hypertriglyceridemia
  Min-Ho Lee, Sunyeong Park, Yinzhu Xu, Jung-Eun Kim, Hengmin Han, Jae-Hyeon Lee, Jean Kyung Paik, Hyo-Jeong Lee
  Applied Sciences.2022; 12(13): 6745.     CrossRef
• TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis
  Yanmei Zhang, Xiaoxiao Ge, Yongqing Li, Bingyang Zhang, Peijun Wang, Mingju Hao, Peng Gao, Yueyi Zhao, Tao Sun, Sumei Lu, Wanshan Ma
  Lipids in Health and Disease.2021;[Epub]     CrossRef
• Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway
  In-Jin Cho, Da-Hee Oh, Jin Yoo, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, Soung Won Jeong, Ju-Young Moon, Sang-Ho Lee, Sung-Jig Lim, In-Kyung Jeong
  Scientific Reports.2021;[Epub]     CrossRef
• Tabebuia rosea (Bertol.) DC. ethanol extract attenuates body weight gain by activation of molecular mediators associated with browning
  Elsa Cecilia Pagaza-Straffon, Carla Elena Mezo-González, David Armando Chavaro-Pérez, Jorge Cornejo-Garrido, Laurence A. Marchat, Claudia G. Benítez-Cardoza, Maricruz Anaya-Reyes, Cynthia Ordaz-Pichardo
  Journal of Functional Foods.2021; 86: 104740.     CrossRef
• Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
  Zhangya He, Xiaomin Li, Hexiang Yang, Pei Wu, Shanshan Wang, Dan Cao, Xiaoxiao Guo, Zhangrui Xu, Jiayi Gao, Wanyu Zhang, Xiaoqin Luo
  Frontiers in Nutrition.2021;[Epub]     CrossRef
• Hepatic lipid droplet homeostasis and fatty liver disease
  Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer
  Seminars in Cell & Developmental Biology.2020; 108: 72.     CrossRef
• Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolism
  Johanna Matilainen, Anne-Mari Mustonen, Kirsi Rilla, Reijo Käkelä, Sanna P. Sihvo, Petteri Nieminen
  Lipids in Health and Disease.2020;[Epub]     CrossRef
• Liver fibrogenesis: un update on established and emerging basic concepts
  Erica Novo, Claudia Bocca, Beatrice Foglia, Francesca Protopapa, Marina Maggiora, Maurizio Parola, Stefania Cannito
  Archives of Biochemistry and Biophysics.2020; 689: 108445.     CrossRef
• Relative contribution of fat diet and physical inactivity to the development of metabolic syndrome and non-alcoholic fat liver disease in Wistar rats
  Antonio Bovolini, Juliana Garcia, Maria Amparo Andrade, José Alberto Duarte
  Physiology & Behavior.2020; 225: 113040.     CrossRef
• Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway
  Li Zhang, Hui-Xia Li, Wu-Si Pan, Farhan Ullah Khan, Cheng Qian, Feng-Rong Qi-Li, Xiaojun Xu
  Biomedicine & Pharmacotherapy.2019; 110: 571.     CrossRef
• Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study
  You‐Cheol Hwang, Hong‐Yup Ahn, Cheol‐Young Park
  Obesity.2019; 27(8): 1360.     CrossRef
• Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
  Hongbo Wang, Zaiming Lu, Xiangxuan Zhao
  Journal of Hematology & Oncology.2019;[Epub]     CrossRef
• Elastography in the Diagnosis of Non-Alcoholic Fatty Liver Disease
  Elena N. Shirokova, Chavdar S. Pavlov, Anna D. Karaseva, Aliya M. Alieva, Alla V. Sedova, Vladimir T. Ivashkin
  Annals of the Russian academy of medical sciences.2019; 74(1): 5.     CrossRef
• Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro
  Xiao-qun Han, San-qing Xu, Jian-guo Lin
  Current Medical Science.2019; 39(5): 766.     CrossRef
• Lipid mediators of liver injury in nonalcoholic fatty liver disease
  Suthat Liangpunsakul, Naga Chalasani
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2019; 316(1): G75.     CrossRef
• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
  Maurizio Parola, Massimo Pinzani
  Molecular Aspects of Medicine.2019; 65: 37.     CrossRef
• Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis
  Lili Nimri, Katerina Staikin, Irena Peri, Einav Yehuda‐Shnaidman, Betty Schwartz
  Journal of Gastroenterology and Hepatology.2018; 33(12): 1990.     CrossRef
• miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
  Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez
  Journal of Hepatology.2018; 69(6): 1335.     CrossRef
• Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells
  Jae Min Cha, Eun Kyoung Shin, Ji Hee Sung, Gyeong Joon Moon, Eun Hee Kim, Yeon Hee Cho, Hyung Dal Park, Hojae Bae, Jinseok Kim, Oh Young Bang
  Scientific Reports.2018;[Epub]     CrossRef
• Changes in the Structure of the Liver during Obesity (Literature Review)
  V. I. Prymachenko
  Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2018; 4(2): 45.     CrossRef
• Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
  Juan Pablo Arab, Marco Arrese, Michael Trauner
  Annual Review of Pathology: Mechanisms of Disease.2018; 13(1): 321.     CrossRef
• Apoptosis and non-alcoholic fatty liver diseases
  Tatsuo Kanda, Shunichi Matsuoka, Motomi Yamazaki, Toshikatsu Shibata, Kazushige Nirei, Hiroshi Takahashi, Tomohiro Kaneko, Mariko Fujisawa, Teruhisa Higuchi, Hitomi Nakamura, Naoki Matsumoto, Hiroaki Yamagami, Masahiro Ogawa, Hiroo Imazu, Kazumichi Kuroda
  World Journal of Gastroenterology.2018; 24(25): 2661.     CrossRef
• Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
  Y Ilan, K Shailubhai, A Sanyal
  Clinical and Experimental Immunology.2018; 193(3): 275.     CrossRef
• Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice
  Karla Frida Torres Flister, Bruno Araújo Serra Pinto, Lucas Martins França, Caio Fernando Ferreira Coêlho, Pâmela Costa dos Santos, Caroline Castro Vale, Daniela Kajihara, Victor Debbas, Francisco Rafael Martins Laurindo, Antonio Marcus de Andrade Paes
  The Journal of Nutritional Biochemistry.2018; 62: 155.     CrossRef
• Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis
  Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang
  Biomarkers in Medicine.2018; 12(5): 501.     CrossRef
• The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
  Bojan Jorgačević, Danijela Vučević, Ivana Đuričić, Slađana Šobajić, Dušan Mladenović, Milena Vesković, Rada Ješić Vukićević, Tatjana Radosavljević
  Chemistry and Physics of Lipids.2017; 204: 85.     CrossRef
• Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition
  Soo Hyun Kim, Gyuri Kim, Dai Hoon Han, Milim Lee, Irene Kim, Bohkyung Kim, Kook Hwan Kim, Young-Mi Song, Jeong Eun Yoo, Hye Jin Wang, Soo Han Bae, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Myung-Shik Lee
  Autophagy.2017; 13(10): 1767.     CrossRef
• Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status
  Ji Hye Huh, Kwang Joon Kim, Seung Up Kim, Seung Hwan Han, Kwang-Hyub Han, Bong-Soo Cha, Choon Hee Chung, Byung-Wan Lee
  Metabolism.2017; 66: 23.     CrossRef
• Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
  Gyuri Kim, Kwang Joon Kim, Yumie Rhee, Sung-Kil Lim, Salvatore Petta
  PLOS ONE.2017; 12(7): e0182202.     CrossRef
• Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
  Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
  PLOS ONE.2017; 12(7): e0180118.     CrossRef
• Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
  Xu-Jia Chen, Wen-Jing Liu, Meng-Liang Wen, Hong Liang, Shao-Mei Wu, Yun-Zhen Zhu, Jiang-Yuan Zhao, Xiang-Qian Dong, Ming-Gang Li, Li Bian, Cheng-Gang Zou, Lan-Qing Ma
  Scientific Reports.2017;[Epub]     CrossRef
• Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH
  Melanie Tran, Sang-Min Lee, Dong-Ju Shin, Li Wang
  JCI Insight.2017;[Epub]     CrossRef
• Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
  Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic
  World Journal of Gastroenterology.2016; 22(44): 9706.     CrossRef
• Hepatocyte mitochondrial DNA released in microparticles and toll‐like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis
  Maria Eugenia Inzaugarat, Alexander Wree, Ariel E. Feldstein
  Hepatology.2016; 64(2): 669.     CrossRef
• Metabolic aspects of adult patients with nonalcoholic fatty liver disease
  Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo
  World Journal of Gastroenterology.2016; 22(31): 7006.     CrossRef
• Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
  Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro
  World Journal of Gastroenterology.2016; 22(36): 8078.     CrossRef
• Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals
  Sabri Rial, Antony Karelis, Karl-F. Bergeron, Catherine Mounier
  Nutrients.2016; 8(5): 281.     CrossRef